Kathryn graduated from the University of St Andrews in 2017 with an MChem in Chemistry with Medicinal Chemistry. She undertook an industrial placement at Randox Laboratories, focusing on developing diagnostic solutions for a range of industries. Back in St Andrews for her final year, her project was based on the development of a library of analogues to a known neutral sphingomyelinase inhibitor, with the aim to develop an improved treatment for African sleeping sickness, a neglected tropical disease. In her spare time, Kathryn enjoys drinking coffee, travelling and playing racket sports.